CELL AND GENE THERAPY AND CONNECTED HEALTH

Since the 1990s, early gene therapy research was underway at the University of Pennsylvania. Today, four FDA-approved therapies are on the market thanks to innovations in our region. They include the first FDA-approved cell therapy, first FDA-approved gene therapy and first FDA-approved aesthetic cell therapy.

More than 30 R&D companies in this space have been founded here, thanks to academic and human resources available in institutions like the University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia , Coriell Institute, Christiana Care Gene Editing Institute, Jefferson Health, Temple University and the Wistar Institute – all of which have the infrastructure and expertise to support the translation of new medicines.